Entity
  • InCarda Therapeutics

    Created in 2009
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    203 3,507
  • Activities

  • Technologies

  • Entity types

  • Location

    39899 Balentine Dr, Newark, CA 94560, USA

    Newark

    United States of America

  • Employees

    Scale: 11-50

    Estimated: 15

  • Engaged corporates

    1
    0 0
  • Added in Motherbase

    1 year, 7 months ago
Description
  • Value proposition

    Pioneering inhaled medications for cardiovascular conditions

    InCarda Therapeutics is a clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).

    Cardiovascular, Inhalation therapy, Biotechnology, Pharmaceuticals, Clinical Development, Drug Formulation, Commercialization, Clinical Research, Pre-Clinical Research, and Regulatory Affairs

Corporate interactions BETA
Corporate TypeTweets Articles
Bayer
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Bayer
Chemistry, Pharmaceutical, Chemical Manufacturing
Other

14 Jan 2020


Similar entities
Loading...
Loading...
Social network dynamics